Different systemic rheumatic diseases as risk factors for COVID-19-related mortality
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Rheumatology
Link
https://link.springer.com/content/pdf/10.1007/s10067-022-06190-3.pdf
Reference30 articles.
1. Kastritis E, Kitas GD, Vassilopoulos D, Giannopoulos G, Dimopoulos MA, Sfikakis PP (2020) Systemic autoimmune diseases, anti-rheumatic therapies, COVID-19 infection risk and patient outcomes. Rheumatol Int 40:1353–1360. https://doi.org/10.1007/s00296-020-04629-x
2. Kroon FPB, Najm A, Alunno A, Schoones JW, Landewe RBM, Machado PM, Navarro-Compan V (2022) Risk and prognosis of SARS-CoV-2 infection and vaccination against SARS-CoV-2 in rheumatic and musculoskeletal diseases: a systematic literature review to inform EULAR recommendations. Ann Rheum Dis 81:422–432. https://doi.org/10.1136/annrheumdis-2021-221575
3. Piaserico S, Gisondi P, Cazzaniga S, Di Leo S, Naldi L (2022) Assessing the risk and outcome of COVID-19 in patients with psoriasis or psoriatic arthritis on biologic treatment: a critical appraisal of the quality of the published evidence. J Invest Dermatol 142(355–363):e357. https://doi.org/10.1016/j.jid.2021.04.036
4. Grainger R, Kim AHJ, Conway R, Yazdany J, Robinson PC (2022) COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations. Nat Rev Rheumatol. https://doi.org/10.1038/s41584-022-00755-x
5. Hyrich KL, Machado PM (2021) Rheumatic disease and COVID-19: epidemiology and outcomes. Nat Rev Rheumatol 17:71–72. https://doi.org/10.1038/s41584-020-00562-2
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Comparison of nailfold capillaroscopy findings in COVID-19 survivors with and without rheumatic disease: a case-control study;Cukurova Medical Journal;2024-03-29
2. Prophylaxis with tixagevimab/cilgavimab is associated with lower COVID-19 incidence and severity in patients with autoimmune diseases;Rheumatology;2023-08-26
3. Outcomes of COVID-19 Omicron variant in patients with rheumatoid arthritis: a nationwide Greek cohort study;Rheumatology;2023-07-19
4. How Did the Two Years of the COVID-19 Pandemic Affect the Outcomes of the Patients with Inflammatory Rheumatic Diseases in Lithuania?;Medicina;2023-02-08
5. COVID-19 and protection of vaccination in patients with systemic sclerosis–associated interstitial lung disease;Journal of Scleroderma and Related Disorders;2022-12-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3